Open access peer-reviewed chapter

B Cells in Health and Disease – Leveraging Flow Cytometry to Evaluate Disease Phenotype and the Impact of Treatment with Immunomodulatory Therapeutics

By Cherie L. Green, John Ferbas and Barbara A. Sullivan

Submitted: June 16th 2011Reviewed: January 26th 2012Published: May 16th 2012

DOI: 10.5772/38288

Downloaded: 2925

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Cherie L. Green, John Ferbas and Barbara A. Sullivan (May 16th 2012). B Cells in Health and Disease – Leveraging Flow Cytometry to Evaluate Disease Phenotype and the Impact of Treatment with Immunomodulatory Therapeutics, Clinical Flow Cytometry - Emerging Applications, Ingrid Schmid, IntechOpen, DOI: 10.5772/38288. Available from:

chapter statistics

2925total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Evaluation of the Anti-Tumoural and Immune Modulatory Activity of Natural Products by Flow Cytometry

By Susana Fiorentino, Claudia Uruena, Sandra Quijano, Sandra Paola Santander, John Fredy Hernandez and Claudia Cifuentes

Related Book

First chapter

What Flow Cytometry can Tell Us About Marine Micro-Organisms – Current Status and Future Applications

By A. Manti, S. Papa and P. Boi

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us